Clinical Trial Update: A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases [NA]

View source ↗

Summary

A pilot study of irinotecan for breast cancer with central nervous system metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Nervous System Metastases

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: University of California, Irvine | Conditions: Central Nervous System Metastases, Male Breast Cancer | NA | Status: WITHDRAWN